Document:

Exhibit 10.33

AMENDMENT No. 1 TO

THE 401(k) SAVINGS PLAN OF

QUEST DIAGNOSTICS INCORPORATED

          The 401(k)
Savings Plan of Quest Diagnostics Incorporated, as presently maintained under
an amendment and restatement effective as of January 1, 2010, is hereby
amended, generally effective as of January 1, 2011, except as specifically
stated herein, in the following respects:

1. Section 5.5(e) is amended in its entirety to provide
as follows:

	
  

 	
  

 
	
  

 	
           “(e)
 Application of Forfeitures — Forfeitures occurring during the Plan Year first
 shall be used to reinstate previously forfeited sub-accounts of reemployed
 Participants, if any, and any remaining forfeitures then will be used either
 to reduce Employer contributions (only Employer Discretionary Contributions
 (if any), effective January 1, 2011) to the Plan, to make corrective
 allocations to the Plan (and earnings on such corrective allocations)
 pursuant to Section 3.11 or to pay Plan expenses.”

 

2. Section 7.6 is amended by
adding the phrase “, and will be administered on a unit accounting basis” at
the end of the first sentence. 

3. Section 8.3(d) is amended in its entirety to provide
as follows:

	
  

 	
  

 	
  

 
	
  

 	
           “(d) The
 Committee has designated the Investment Committee, whose members need not be
 members of the Committee, as the “named fiduciary” of the Plan, as that term
 is defined in ERISA Section 402(a)(2) with respect to investments of the Plan
 other than the Quest Diagnostics Incorporated Stock Fund. The discretionary
 authority of the Investment Committee shall include the responsibility to
 select, monitor and to replace Investment Options (other than the Quest
 Diagnostics Incorporated Stock Fund), to designate default Investment
 Option(s), to retain and discharge investment managers and to make other
 investment-related discretionary decisions; provided that neither the
 Committee nor its designate (including the Investment Committee) has:

 
	
  

 	
  

 	
  

 
	
  

 	
  

 	
           (1)
 responsibility for monitoring the performance of the Quest Diagnostics
 Incorporated Stock Fund; or

 
	
  

 	
  

 	
  

 
	
  

 	
  

 	
           (2)
 authority to take any action with respect to the Quest Diagnostics
 Incorporated Stock Fund or its operation, other than with respect to the
 amount of liquidity that is appropriate to be maintained within this fund and
 the investment of such liquid assets. 

 
	
  

 	
  

 	
  

 
	
  

 	
 The
 Investment Committee also shall establish, or cause to be established,
 investment guidelines consistent with the objectives of the Plan and the
 requirements of ERISA.

 

4. Appendix A is amended in its
entirety, effective January 1, 2012, to provide as follows in the attached
Appendix A.

5. In all other respects, the Plan shall remain unchanged
by this Amendment.

          As evidence
of its adoption of this Amendment, Quest Diagnostics Incorporated has caused
this instrument to be signed by its authorized officer this 21st day of
December, 2011, generally effective as of January 1, 2011, except as
specifically stated herein or as may be required by applicable law.

	
  

 	
  

 	
  

 	
  

 
	
  

 	
 QUEST DIAGNOSTICS INCORPORATED

 
	
  

 	
  

 	
  

 
	
  

 	
 By:

 	
 /s/ David W.
 Norgard

 
	
  

 	
  

 	

 

 
	
  

 	
  

 	
  

 
	
  

 	
 Title: 

 	
 Vice
 President, Human Resources

 
	
  

 	
  

 	

 

 

2

Appendix A 

The Plan
allows employers other than the Corporation to adopt its provisions. Except as
specifically provided below, the names of participating employers (and
jurisdictions of organization) as of January 1, 2012, of this Plan are:

	
  

 
	
 A. Bernard
 Ackerman, M.D. Dermatopathology, PC (NY)

 
	
 AmeriPath
 5.01(a) Corporation (TX)

 
	
 AmeriPath
 Cincinnati, Inc. (OH)

 
	
 AmeriPath
 Cleveland, Inc. (OH)

 
	
 AmeriPath
 Consolidated Labs, Inc. (FL)

 
	
 AmeriPath
 Consulting Pathology Services, P.A. (NC)

 
	
 AmeriPath
 Florida, LLC (DE)

 
	
 AmeriPath
 Group Holdings, Inc. (DE)

 
	
 AmeriPath
 Indemnity, Ltd. (Cayman Islands)

 
	
 AmeriPath
 Indiana, LLC (IN)

 
	
 AmeriPath
 Indianapolis, P.C. (IN)

 
	
 AmeriPath
 Institute of Urological Pathology, PC (MI)

 
	
 AmeriPath
 Kentucky, Inc. (KY)

 
	
 AmeriPath
 Lubbock 5.01(a) Corporation (TX)

 
	
 AmeriPath
 Lubbock Outpatient 5.01(a) Corporation 

 
	
 AmeriPath
 Marketing USA, Inc (FL)

 
	
 AmeriPath
 Michigan, Inc. (MI)

 
	
 AmeriPath
 Milwaukee, S.C. (WI)

 
	
 AmeriPath
 Mississippi, Inc. (MS)

 
	
 AmeriPath
 New York, LLC (DE)

 
	
 AmeriPath
 North Carolina, Inc. (NC)

 
	
 AmeriPath
 Ohio, Inc. (DE)

 
	
 AmeriPath
 PAT 5.01(a) Corporation (TX)

 
	
 AmeriPath
 Pennsylvania, LLC (PA)

 
	
 AmeriPath
 Philadelphia, Inc. (NJ)

 
	
 AmeriPath
 Pittsburgh, P.C. (PA)

 
	
 AmeriPath
 SC, Inc. (SC)

 
	
 AmeriPath
 Texarkana 5.01(a) Corporation (TX)

 
	
 AmeriPath
 Texas, LP

 
	
 AmeriPath
 Tucson, Inc. (AZ)

 
	
 AmeriPath
 Wisconsin, LLC (WI)

 
	
 AmeriPath
 Youngstown Labs, Inc. (OH)

 
	
 AmeriPath
 Youngstown, Inc. (OH)

 
	
 AmeriPath,
 Inc. (DE)

 
	
 AmeriPath,
 LLC (DE)

 
	
 Anatomic Pathology
 Services, Inc. (OK)

 
	
 API No. 2,
 LLC (DE)

 
	
 Arizona
 Pathology Group, Inc. (AZ)

 
	
 Arlington
 Pathology Association 5.01(a) Corporation (TX)

 
	
 Colorado
 Diagnostic Laboratory, LLC (CO)

 
	
 Colorado
 Pathology Consultants, P.C. (CO)

 
	
 Consulting
 Pathologists of Pennsylvania, P.C. (PA)

 
	
 Dermatopathology
 of Wisconsin, S.C. (WI)

 
	
 Dermatopathology
 Services, Inc. (AL)

 
	
 DFW 5.01(a)
 Corporation (TX)

 
	
 Diagnostic
 Pathology Management Services, LLC (OK)

 
	
 Diagnostic
 Pathology Services, P.C. (OK)

 
	
 Institute
 for Dermatopathology, P.C. (PA)

 
	
 Kailash B.
 Sharma, M.D., Inc. (GA)

 
	
 Kilpatrick
 Pathology, P.A. (NC)

 
	
 NAPA 5.01(a)
 Corporation (TX)

 
	
 Nuclear
 Medicine and Pathology Associates (GA)

 
	
 O’Quinn
 Medical Pathology Association, LLC (GA) 

 
	
 Ocmulgee
 Medical Pathology Association, Inc. (GA)

 
	
 PCA of Denver, Inc. (TN)

 
	
 PCA of
 Nashville, Inc. (TN)

 
	
 Peter G. Klacsmann, M.D., Inc. (GA)

 
	
 Regional
 Pathology Consultants, LLC (UT)

 
	
 Rocky
 Mountain Pathology, LLC (UT) 

 
	
 Rose
 Pathology Associates, P.C. (CO)

 
	
 Sharon G.
 Daspit, M.D., Inc. (GA)

 
	
 Shoals
 Pathology Associates, Inc. (AL)

 
	
 Southwest
 Diagnostic Laboratories, P.C. (CO)

 
	
 St. Luke’s
 Pathology Associates, P.A. (KS)

 
	
 Strigen, Inc. (UT)

 
	
 TID Acquisition Corp. (DE)

 
	
 Tulsa Diagnostics, P.C. (OK)

 
	
 TXAR 5.01(a)
 Corporation (TX)Exhibit 10.38

AMENDMENT No. 5 TO

THE PROFIT SHARING PLAN OF

QUEST DIAGNOSTICS INCORPORATED

          The Profit Sharing Plan of
Quest Diagnostics Incorporated, whose predecessor was originally effective
October 1, 1973, as presently maintained under an amendment and restatement
made effective as of January 1, 2007, and as amended from time to time
thereafter, is hereby further amended, generally effective as of January 1,
2011 except as specifically stated herein or as may be required by applicable
law, in the following respects:

1. A new definition is added to Section 1.1 to provide as
follows:

          “Appeals
Committee – The Appeals Committee, as provided for in Section 8.1.”

2. A new definition is added to Section 1.1 to provide as
follows:

          “Investment
Committee – The Investment Committee, as provided for in Section 8.1.”

3. The definition of “Investment Option” in
Section 1.1 is amended in its entirety to provide as follows:

	
  

 	
  

 	
  

 	
  

 
	
  

 	
 “Investment Option– The investment vehicle elected by the
 Participant in accordance with Section 2.4 for investment of his Individual
 Account. The Employer Stock Fund shall at all times be an available Investment
 Option under this Plan.”

 
	
  

 	
  

 	
  

 	
  

 
	
 4. Section 3.1(b)(7) is amended in its entirety,
 effective January 1, 2012, to provide as follows:

 
	
  

 	
  

 	
  

 	
  

 
	
  

 	
  

 	
 “(7)

 	
 In order to make a Catch-Up Pre-Tax Contribution, a Participant must
 either be making a Regular Pre-Tax Contribution of at least 5% of Deferral
 Compensation or have reached the Code Section 402(g) limit.”

 
	
  

 	
  

 	
  

 	
  

 
	
 5. Section 3.2 is
 amended in its entirety, effective January 1, 2012, to provide as follows:

 
	
  

 	
  

 	
  

 
	
  

 	
 “3.2

 	
 Employer
 Matching Contributions

 
	
  

 	
  

 	
  

 
	
  

 	
  

 	
 Subject to Section 3.5, for paydates on or after January 6, 2012 the
 Employer shall make Employer Matching Contributions to the Trust Fund equal
 to 100% of the Regular Pre‐Tax Contributions made by each Participant
 with respect to each payroll period, but taking into account only those
 Regular Pre-Tax Contributions made by the Participant with respect to such
 payroll period which are made at a rate that does not exceed 5% of the
 Participant’s Deferral Compensation. The Employer shall not make Employer
 Matching Contributions with respect to Catch-Up Pre-Tax Contributions, except
 for Catch-Up Pre-Tax Contributions that have been recharacterized as Regular
 Pre-Tax Contributions pursuant to Section 3.1(b)(6).

 
	
  

 	
  

 	
  

 
	
  

 	
  

 	
 A Participant may designate that his
 Employer Stock Matching Sub-Account be invested in accordance with the
 Investment Option specification designated by the 

 

	
  

 	
  

 
	
  

 	
 Participant for the investment of Regular
 Pre-Tax Contributions. Pursuant to Section 2.4(b), a Participant may change
 such Investment Option specification. In the absence of a valid Investment
 Option specification to the contrary, a Participant’s Employer Stock Matching
 Sub-Account shall remain invested in the Employer Stock Fund.

 
	
  

 	
  

 
	
  

 	
 The entire Employer Matching Contribution shall be invested in
 accordance with the Investment Option specification designated by the
 Participant for the investment of Regular Pre-Tax Contributions and shall be
 held in the Employer Matching Sub-Account.

 
	
  

 	
  

 
	
  

 	
 Notwithstanding anything in this Section 3.2 to the contrary,
 effective January 1, 2012, if the Code Section 402(g) limit is less than 5%
 of the Code Section 401(a)(17) limit when a Non-highly Compensated Employee
 makes Regular Pre-tax Contributions equal to the Code Section 402(g) limit
 and also makes Catch-up Pre-tax Contributions then the Non-highly Compensated
 Employee will receive Employer Matching Contributions on his Catch-up Pre-tax
 Contributions. Notwithstanding, the Non-highly Compensated Employee will only
 receive Employer Matching Contributions on his Catch-up Pre-tax Contributions
 to the extent necessary to meet the matching contributions formula of this
 Section 3.2.”

 

6. Section 3.12 is amended in its entirety to provide as
follows:

	
  

 	
  

 	
  

 	
  

 
	
  

 	
 “3.12

 	
 Corrective
 Contributions

 
	
  

 	
  

 	
  

 	
  

 
	
  

 	
  

 	
 (a)

 	
 If it becomes necessary to correct a failure to follow the provisions
 of the Plan, to correct mistakes made in amounts distributed from or credited
 to Accounts, to restore the portion of an Account that was forfeited pursuant
 to any provision of the Plan or if an Employee should have been included as a
 Participant but is mistakenly excluded for any reason, correction or
 restoration shall first be made out of Employer contributions and forfeitures
 and then out of Trust Fund earnings for the Plan Year in question, but only
 to the extent that such amounts have not already been allocated under the
 provisions of the Plan. Any additional amounts needed may be provided by a
 special contribution to the Plan which the Employers, in their sole
 discretion (but subject to the applicable limitations on deductible
 contributions and maximum annual additions and considering the rules on
 deductibility under Code Section 162), may elect to make. Any such correction
 of mistake or special contribution shall be corrected, allocated or credited
 in the fashion specified by the Plan Administrator. 

 
	
  

 	
  

 	
  

 	
  

 
	
  

 	
  

 	
 (b)

 	
 The provisions of this subsection (b) shall apply only to an Employee
 or former Employee who becomes entitled to back pay by an award or agreement
 of an Employer without regard to mitigation of damages. If a person to whom
 this subsection applies was or would have become an Eligible Employee after
 such back pay award or agreement has been effected, and if he had not
 previously elected to make Employee Pre-Tax Contributions pursuant to Section
 3.1 but, within 30 days of the date he 

 

2

	
  

 	
  

 	
  

 	
  

 
	
  

 	
  

 	
  

 	
 receives notice of the provisions of this Section, makes an election
 to make Employee Pre-Tax Contributions in accordance with Section 3.1
 (retroactive to any date as of which he was or has become eligible to do so),
 then he may elect that any Employee Pre-Tax Contributions not previously made
 on his behalf but which, after application of the foregoing provisions of
 this subsection, would have been made under the provisions of Article III
 shall be made out of the proceeds of such back pay award or agreement. In
 addition, if any such Employee or former Employee would have been eligible to
 participate in the allocation of Employer Matching or Discretionary
 Contributions under the provisions of Articles III or XI for any prior Plan
 Year after such back pay award or agreement has been effected, his Employer
 shall make Employer Matching and Discretionary Contributions equal to the
 amount of the Employer Matching and Discretionary Contributions
 (respectively) which would have been allocated to him under the provisions of
 Articles III or XI as in effect during each such Plan Year. The amounts of
 such additional contributions shall be credited to his Account. Any
 additional contributions made pursuant to this subsection shall be made in
 accordance with, and subject to the limitations of, the applicable provisions
 of the Plan.”

 
	
  

 	
  

 	
  

 	
  

 
	
 7. Section 4.5 is
 amended in its entirety to provide as follows:

 
	
  

 	
  

 	
  

 	
  

 
	
  

 	
 “4.5

 	
 Allocation of Forfeitures

 
	
  

 	
  

 	
  

 	
  

 
	
  

 	
  

 	
 Any Forfeitures arising under Section 5.5(b)(3) shall be used to the
 extent necessary to restore a reemployed Participant’s Prior ESOP Employer
 Stock Sub-Account, Prior ESOP Employer Contributions Sub-Account, Prior
 Employer Match Sub-Account, a Prior Focus Plan Match Sub‐Account, Prior
 Employer Five-Year Sub-Account, Prior Employer Six-Year Money Purchase
 Sub-Account, Prior Employer Six-Year Sub-Account, or Prior Unilab Employer
 Contribution Sub-Account as provided in Section 5.5(b)(3) and/or shall be
 applied to reduce Employer Contributions (including corrective allocations
 made to the Plan and earnings on such corrective allocations pursuant to
 Section 3.12) and/or shall be used to pay Plan expenses.”

 
	
  

 	
  

 	
  

 	
  

 
	
 8. Section 7.3 is
 amended in its entirety to provide as follows:

 
	
  

 	
  

 	
  

 	
  

 
	
  

 	
 “7.3

 	
 Employer Stock Fund

 
	
  

 	
  

 	
  

 	
  

 
	
  

 	
  

 	
 One of the Investment Options shall be the Employer Stock Fund, which
 will be invested in Employer Stock, provided such stock qualifies as
 qualifying employer securities within the meaning of ERISA Section 407(d)(5),
 and will be administered on a unit accounting basis. The Plan is intended to
 be an eligible individual account plan under ERISA Section 407(d)(3). The
 portion of the Plan comprised of the Employer Stock Fund shall be an employee
 stock ownership plan under Code Sections 409 and 4975(e)(7) which shall
 include the share distribution requirements of Code Section 409(h) and the
 participant pass-through voting rights required under Code Section 409(e).
 The level of Plan assets invested in such fund shall be determined by
 Participants’ Investment Option 

 

3

	
  

 	
  

 	
  

 	
  

 
	
  

 	
  

 	
 specifications and, subject to any restrictions that may be imposed
 under Section 2.4, may consist of up to 100% of all Plan assets; provided
 that in no event may any portion of a Participant’s Account be required to be
 maintained in the Employer Stock Fund. With respect to the Employer Stock
 Fund, the Plan is intended to comply with the Corporation’s securities law
 compliance policy and with applicable federal securities laws.”

 
	
  

 	
  

 	
  

 	
  

 
	
 9. Clause (3) in
 the third paragraph of Section 8.1 is amended to provide as follows:

 
	
  

 	
  

 	
  

 	
  

 
	
  

 	
  

 	
 “(3) delegation by the Committee to another committee (the “Investment
 Committee”) of the responsibility to add, change or delete Investment Options
 (other than the Employer Stock Fund) and make other investment-related
 discretionary decisions, or to another committee (the “Appeals Committee”) of
 the responsibility to make final determinations of claims for benefits, to
 determine eligibility for benefits and to resolve any situation not
 specifically covered by the provisions of the Plan.”

 
	
  

 	
  

 	
  

 	
  

 
	
 10. A new
 paragraph is added at the end of Section 8.5 to provide as follows:

 
	
  

 	
  

 	
  

 	
  

 
	
  

 	
  

 	
 “Notwithstanding any other provision of the Plan to the contrary, the
 Committee has designated the Investment Committee, whose members need not be
 members of the Committee, to review and monitor the Investment Options (other
 than the Employer Stock Fund) under the Plan, and at any time to add, change
 or delete the available Investment Options (other than the Employer Stock
 Fund) and make other investment-related discretionary decisions; provided
 that neither the Committee nor or its designate (including the Investment
 Committee) has the power to remove the Quest Diagnostics Incorporated Stock
 Fund as an available Investment Option under the Plan. Neither the Committee
 nor its designate (including the Investment Committee) has responsibility for
 monitoring the performance of the Employer Stock Fund or authority to take
 any action with respect to the Employer Stock Fund or its operation, other
 than with respect to the amount of liquidity that is appropriate to be
 maintained within this fund and the investment of such liquid assets. The
 Investment Committee also shall establish, or cause to be established,
 investment guidelines consistent with the objectives of the Plan and the
 requirements of ERISA.”

 
	
  

 	
  

 	
  

 	
  

 
	
 11. Effective
 June 1, 2007, Section 11.1(a)(2)(A) is amended by replacing the term
 “separation from service” with the term “severance from employment.”

 
	
  

 
	
 12. A new Section
 12.10 is added to the Plan to provide as follows:

 
	
  

 
	
  

 	
 “12.10

 	
 Recovery of Overpayment

 
	
  

 	
  

 	
  

 	
  

 
	
  

 	
  

 	
 If the Plan makes an overpayment, the Plan has the right at any time
 to, as elected by the Plan Administrator:

 

	
  

 	
  

 	
  

 
	
  

 	
 (a)

 	
 recover that
 overpayment from the person to whom it was made;

 
	
  

 	
  

 	
  

 
	
  

 	
 (b)

 	
 offset the
 amount of that overpayment from a future payment; or

 
	
  

 	
  

 	
  

 
	
  

 	
 (c)

 	
 a
 combination of both.

 

4

	
  

 	
  

 
	
  

 	
 The Plan shall be considered to have established an equitable lien by
 agreement with the person to whom such overpayment was made. Such payee
 shall, upon request, execute and deliver such instruments and papers as may
 be required, and shall do whatever else is necessary, to secure such rights
 of recovery to the Plan.”

 

13. Appendix A is amended in its entirety to provide as
follows in the attached Appendix A.

14. In all other respects, the Plan shall remain
unchanged by this Amendment.

5

          As evidence
of its adoption of this Amendment, Quest Diagnostics Incorporated has caused
this instrument to be signed by its authorized officer this 21st day of
December, 2011, generally effective as of January 1, 2011, except as
specifically stated herein or as may be required by applicable law.

	
  

 	
  

 	
  

 	
  

 
	
  

 	
 QUEST DIAGNOSTICS INCORPORATED

 
	
  

 	
  

 	
  

 
	
  

 	
 By:

 	
 /s/ David W.
 Norgard

 
	
  

 	
  

 	

 

 
	
  

 	
  

 	
  

 
	
  

 	
 Title: 

 	
 Vice
 President, Human Resources

 
	
  

 	
  

 	

 

 

6

Appendix
A

The Plan allows employers other than Quest Diagnostics to adopt its
provisions. Except as specifically provided below, the names of participating
employers (and jurisdictions of organization) as of January 1, 2012, of this
Plan are:

	
  

 
	
 ADI Holding
 Company, Inc (DE) (participation began 4/11)

 
	
 American
 Medical Laboratories, Incorporated (DE)

 
	
 APL
 Properties Limited Liability Company (NV)

 
	
 Associated
 Clinical Laboratories of Pennsylvania, L.L.C. (PA)

 
	
 Athena Diagnostics, Inc. (DE) (participation began 4/11)

 
	
 Axys Pharmaceuticals, Inc. (DE)

 
	
 Berkeley HeartLab, Inc. (CA)

 
	
 C & S
 Clinical Laboratory, Inc. (NJ) 

 
	
 Celera Corporation (DE)

 
	
 Celera Diagnostics, LLC (DE)

 
	
 Central Plains Holdings, Inc. (KS)

 
	
 CompuNet
 Clinical Laboratories (OH)

 
	
 Diagnostic
 Path Lab, Inc. (TX)

 
	
 Diagnostic Reference Services Inc. (MD)

 
	
 Enterix Inc. (DE)

 
	
 ExamOne LLC (DE)

 
	
 ExamOne
 World Wide of NJ, Inc. (NJ)

 
	
 ExamOne
 World Wide, Inc. (PA)

 
	
 Focus Diagnostics, Inc. (DE)

 
	
 HemoCue, Inc. (CA)

 
	
 LabOne of Ohio, Inc.
 (DE)

 
	
 LabOne, Inc. (MO)

 
	
 LabOne, L.L.C. (KS)

 
	
 MedPlus,
 Inc. (OH) 

 
	
 MetWest Inc.
 (DE)

 
	
 Nichols
 Institute Diagnostics (CA)

 
	
 Nomad
 Massachusetts, Inc. (MA)

 
	
 North Coast
 General Services, Inc. (PA)

 
	
 OralDNA Labs, Inc. (DE)

 
	
 Quest Diagnostics Clinical Laboratories, Inc. (DE)

 
	
 Quest Diagnostics Finance Incorporated (DE)

 
	
 Quest Diagnostics Holdings Incorporated (DE) 

 
	
 Quest Diagnostics Incorporated (MD)

 
	
 Quest Diagnostics Incorporated (MI)

 
	
 Quest Diagnostics Incorporated (NV)

 
	
 Quest Diagnostics Investments Incorporated (DE)

 
	
 Quest Diagnostics LLC (CT)

 
	
 Quest Diagnostics LLC (IL)

 
	
 Quest Diagnostics LLC (MA)

 
	
 Quest Diagnostics Nichols Institute (CA)

 
	
 Quest Diagnostics Nichols Institute, Inc. (VA)

 
	
 Quest Diagnostics of Pennsylvania Inc. (DE)

 
	
 Quest Diagnostics Provider Network, LLC (CO)

 
	
 Quest Diagnostics Receivables Inc. (DE)

 
	
 Quest Diagnostics Venture LLC (PA)

 
	
 Quest Diagnostics Ventures LLC (DE)

 
	
 Specialty
 Laboratories, Inc. (CA)

 
	
 Unilab
 Corporation (DE)

 
	
 Valcor
 Associates Inc. (PA)

 
	
  

 
	
 Associated
 Pathologists, Chartered (NV)

 
	
 Associated
 Diagnostics Pathologists, Inc. (CA)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}]]